Metraipolis › archive › dc_1836eea4adef

Microneedle-nanoparticle hybrid platforms for metabolic syndrome: advances in point-of-care diagnostics and transdermal therapeutics — Europe PMC PMID:41148421

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41148421
DOI
10.1186/s11671-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-09T00:25:39.994Z
SHA-256 of the archived text
63abbaddebf720d99fc9ada13226ed587f6f45348c2c020b15895bb9c7ca9a05
Stable URL of this page
https://metraipolis.com/documento/dc_1836eea4adef

How to cite

Microneedle-nanoparticle hybrid platforms for metabolic syndrome: advances in point-of-care diagnostics and transdermal therapeutics — Europe PMC PMID:41148421 — Europe PMC (en), https://europepmc.org/article/MED/41148421 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1836eea4adef (Metraipolis archive dc_1836eea4adef, sha256 63abbaddebf720d99fc9ada13226ed587f6f45348c2c020b15895bb9c7ca9a05)
BibTeX
@misc{dc1836eea4adef,
  title = {Microneedle-nanoparticle hybrid platforms for metabolic syndrome: advances in point-of-care diagnostics and transdermal therapeutics — Europe PMC PMID:41148421},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41148421},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1836eea4adef; sha256 63abbaddebf720d99fc9ada13226ed587f6f45348c2c020b15895bb9c7ca9a05},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41148421. Agents can read the archived copy with the MCP tool read_document.